Objective: To determine if blood neurofilament light chain (NfL) protein can discriminate between Parkinson disease (PD) and atypical Parkinsonian disorders (APD) with equally high diagnostic accuracy as CSF NfL, and can therefore improve the diagnostic workup of parkinsonian disorders.
Methods: The study included 3 independent prospective cohorts: the Lund (n = 278) and London (n = 117) cohorts,
The post Blood-based NfL – A biomarker for Differential Diagnosis of parkinsonian disorder appeared first on Palm Beach Neurological Center.
This post first appeared on News & Announcements Archives - Palm Beach Neurolo, please read the originial post: here
